V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213101 | 20129136 | 1.77 | 58.6 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-16 | null | 02 | N | PANITUMUMAB | 100965375 |
| 20213105 | 20129138 | 1.65 | 73.3 | Palliative (P) | 2021-07-29 | 2021-08-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100764987 |
| 20213106 | 20129139 | null | 69.7 | Palliative (P) | 2019-05-24 | 2019-06-14 | null | 02 | N | ECX | 101728715 |
| 20213112 | 20129140 | 1.64 | 67 | null | 2017-07-19 | 2017-08-22 | ECX | 02 | null | ECX | 100387530 |
| 20213115 | 20129142 | 1.85 | 55.4 | Neo-adjuvant (N) | 2016-08-28 | 2016-09-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101614706 |
| 20213119 | 20129143 | 1.75 | 84.7 | null | null | 2020-05-23 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 100711263 |
| 20213121 | 20129144 | 1.77 | 70 | null | 2017-05-02 | 2017-07-09 | Panitumumab | N | null | PANITUMUMAB | 101786191 |
| 20213122 | 20129145 | 1.61 | 60 | null | null | 2017-02-16 | Panitumumab | 02 | null | PANITUMUMAB | 100346548 |
| 20213126 | 20129147 | 1.81 | 75.6 | Neo-adjuvant (N) | 2018-06-27 | 2018-07-11 | null | N | N | ECX | 100450167 |
| 20213127 | 20129148 | 1.59 | null | Palliative (P) | 2017-06-28 | 2017-07-08 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101443125 |
| 20213130 | 20129149 | null | null | null | 2016-05-27 | 2016-06-07 | null | 02 | null | NIVOLUMAB | 101518676 |
| 20213131 | 20129150 | 1.93 | 62.3 | 03 | 2018-05-23 | 2018-06-14 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100734387 |
| 20213134 | 20129151 | 1.8 | 95.8 | Palliative (P) | 2018-06-05 | 2018-06-20 | Panitumumab | N | N | PANITUMUMAB | 100707123 |
| 20213135 | 20129152 | null | 89.1 | Palliative (P) | null | 2017-05-01 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100999093 |
| 20213142 | 20129154 | 1.6 | null | Palliative (P) | 2020-06-19 | 2020-08-05 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101024286 |
| 20213143 | 20129155 | 1.8 | 73.3 | null | 2017-05-03 | 2017-05-19 | null | null | null | PANITUMUMAB | 100024667 |
| 20213144 | 20129156 | 1.8 | 44 | null | 2017-09-21 | 2017-10-10 | ECX | null | N | ECX | 101511701 |
| 20213146 | 20129157 | 1.76 | 80 | null | null | 2019-05-16 | null | N | null | ECX | 101671803 |
| 20213148 | 20129158 | 1.58 | 74.5 | null | 2021-07-26 | 2021-08-09 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101056893 |
| 20213150 | 20129159 | 1.56 | 66 | Curative (C) | null | null | null | null | N | CISPLATIN + FLUOROURACIL | 100243840 |
| 20213151 | 20129160 | null | 74 | Palliative (P) | 2021-02-05 | 2022-02-27 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101360972 |
| 20213153 | 20129161 | 1.55 | 64.2 | null | 2016-04-10 | 2016-04-21 | Panitumumab | 02 | null | PANITUMUMAB | 100889180 |
| 20213154 | 20129162 | 1.65 | 73.3 | null | 2019-12-22 | 2020-03-16 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101235255 |
| 20213156 | 20129163 | 1.5 | 88 | null | 2021-03-13 | 2021-03-13 | null | 02 | null | NIVOLUMAB | 100388992 |
| 20213158 | 20129164 | 1.85 | null | Palliative (P) | 2016-02-23 | 2016-02-23 | null | N | N | PANITUMUMAB | 101325699 |
| 20213159 | 20129165 | 1.76 | 54.8 | null | 2021-03-06 | 2021-03-28 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100026717 |
| 20213160 | 20129166 | 1.65 | 81.6 | Neo-adjuvant (N) | 2017-06-07 | 2018-05-10 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100933067 |
| 20213161 | 20129167 | 1.46 | null | Palliative (P) | null | 2017-01-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100665035 |
| 20213163 | 20129168 | 1.6 | 56.7 | null | 2019-06-10 | 2019-06-30 | CISPLATIN + FLUOROURACIL + RT | N | null | CISPLATIN + FLUOROURACIL | 101153943 |
| 20213164 | 20129169 | 1.56 | 65.6 | null | 2018-08-23 | 2019-01-24 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101637540 |
| 20213165 | 20129170 | 1.87 | 68.6 | Palliative (P) | 2019-02-09 | 2019-02-27 | ECX | N | N | ECX | 101449326 |
| 20213169 | 20129173 | null | null | null | 2016-08-10 | 2016-08-19 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100958637 |
| 20213177 | 20129177 | null | null | Palliative (P) | 2018-08-14 | 2018-09-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100073072 |
| 20213179 | 20129178 | 1.6 | 83.8 | Neo-adjuvant (N) | 2017-04-05 | 2017-07-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100964980 |
| 20213180 | 20129179 | 1.78 | 105.1 | null | 2019-10-15 | 2019-11-08 | ECX | N | Y | ECX | 100101736 |
| 20213182 | 20129180 | 1.57 | 66.4 | null | 2018-10-17 | 2018-11-17 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101290203 |
| 20213187 | 20129181 | null | null | Palliative (P) | 2022-04-22 | 2022-05-03 | ECX | null | N | ECX | 101608967 |
| 20213189 | 20129182 | 1.56 | null | Neo-adjuvant (N) | 2020-04-26 | 2020-07-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100756211 |
| 20213190 | 20129183 | 1.53 | 63.9 | 03 | null | 2016-12-01 | null | null | N | ECX | 101195309 |
| 20213191 | 20129184 | null | 67 | null | null | 2017-02-14 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101484197 |
| 20213201 | 20129189 | 1.8 | null | Palliative (P) | 2018-11-19 | 2018-12-12 | null | 2 | N | PANITUMUMAB | 101169661 |
| 20213203 | 20129190 | 1.87 | 72 | Adjuvant (A) | 2018-05-19 | 2018-06-14 | null | N | N | ECX | 100788053 |
| 20213206 | 20129191 | null | 53 | Palliative (P) | 2020-03-29 | 2020-04-09 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101246195 |
| 20213207 | 20129192 | 1.9 | 87.9 | Adjuvant (A) | 2019-01-11 | 2019-01-17 | null | 02 | N | ECX | 101425691 |
| 20213208 | 20129193 | 1.5 | 72.65 | Palliative (P) | 2018-06-29 | 2018-07-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100552216 |
| 20213210 | 20129194 | null | null | 03 | 2017-03-22 | 2017-08-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101254155 |
| 20213212 | 20129195 | null | 82 | 03 | 2017-08-03 | 2017-08-13 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101171606 |
| 20213213 | 20129196 | null | null | Palliative (P) | 2020-11-12 | 2020-11-30 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101058242 |
| 20213214 | 20129197 | 1.77 | 56.5 | null | null | 2018-09-18 | Panitumumab | 2 | null | PANITUMUMAB | 100326496 |
| 20213215 | 20129198 | null | 102.4 | null | null | 2018-09-17 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100611832 |